Sotera Health Company

SHCNASDAQHealthcare● Active

$15.82

+$0.20(+1.29%)

Market Cap$4.5B

P/E Ratio—

52W High$19.85

52W Low$10.795

Avg Volume3.7M

Open$15.69

Beta1.80

Insider Trades Ownership Employees

Sotera Health Company (SHC) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · SHC · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Sotera Health Company insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

SHC insider buying and selling by quarter

SHC insider selling · SHC insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

47.0M23.5M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · SHC ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

SHC executive sell shares · SHC board member insider trading · SHC insider trading SEC filing

Showing 28 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 26, 2026	SHADER ALTON CEO · Director	Award	203,634	—	—	579,573	Form 4
Mar 2, 2026	Petras Michael B. Jr. Chairman & CEO · Director	Award	240,248	—	—	692,427	Form 4
Mar 2, 2026	Petras Michael B. Jr. Chairman & CEO · Director	Option	89,686	—	—	570,835	Form 4
Mar 2, 2026	Petras Michael B. Jr. Chairman & CEO · Director	Other	39,552	$15.91	$629K	531,283	Form 4
Mar 2, 2026	Petras Michael B. Jr. Chairman & CEO · Director	Other	40,302	$15.91	$641K	481,149	Form 4
Mar 2, 2026	Petras Michael B. Jr. Chairman & CEO · Director	Other	79,104	$15.91	$1.26M⚡	452,179	Form 4
Mar 2, 2026	DIMITRIEF ALEXANDER SVP, General Counsel and Sec.	Option	16,816	—	—	343,600	Form 4
Mar 2, 2026	DIMITRIEF ALEXANDER SVP, General Counsel and Sec.	Other	23,619	$15.91	$376K	319,981	Form 4
Mar 2, 2026	Lyons Jonathan M. Sr. Vice President, CFO	Award	59,355	—	—	228,620	Form 4
Mar 2, 2026	Lyons Jonathan M. Sr. Vice President, CFO	Option	17,937	—	—	201,493	Form 4
Mar 2, 2026	Lyons Jonathan M. Sr. Vice President, CFO	Other	23,988	$15.91	$382K	177,505	Form 4
Mar 2, 2026	Lyons Jonathan M. Sr. Vice President, CFO	Other	8,240	$15.91	$131K	169,265	Form 4
Mar 2, 2026	Rutz Michael P President of Sterigenics	Award	45,223	—	—	484,279	Form 4
Mar 2, 2026	Rutz Michael P President of Sterigenics	Option	14,573	—	—	456,553	Form 4
Mar 2, 2026	Rutz Michael P President of Sterigenics	Other	4,495	$15.91	$72K	441,980	Form 4
Mar 2, 2026	Rutz Michael P President of Sterigenics	Other	17,497	$15.91	$278K	439,056	Form 4
Dec 8, 2025	Petras Michael B. Jr. Chairman & CEO · Director	Sale	394,861	$16.45	$6.50M⚡	4,819,393	Form 4
Dec 8, 2025	Petras Michael B. Jr. Chairman & CEO · Director	Sale	39,243	$16.45	$646K	0	Form 4
Aug 22, 2025	Rutz Michael P President of Sterigenics	Sale	126,611	$16.38	$2.07M⚡	450,204	Form 4
Mar 3, 2025	Petras Michael B. Jr. Chairman & CEO · Director	Award	298,953	—	—	868,603	Form 4
Mar 2, 2025	Petras Michael B. Jr. Chairman & CEO · Director	Other	31,872	$12.47	$397K	610,637	Form 4
Mar 2, 2025	Petras Michael B. Jr. Chairman & CEO · Director	Other	40,987	$12.47	$511K	569,650	Form 4
Mar 3, 2025	Rutz Michael P President of Sterigenics	Award	48,579	—	—	576,815	Form 4
Mar 2, 2025	Rutz Michael P President of Sterigenics	Other	4,198	$12.47	$52K	533,635	Form 4
Mar 2, 2025	Rutz Michael P President of Sterigenics	Other	5,399	$12.47	$67K	528,236	Form 4

SHADER ALTON

CEO · Director

Award

Date

May 26

203,634

Price

—

Value

—

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Award

Date

Mar 2

240,248

Price

—

Value

—

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Option

Date

Mar 2

89,686

Price

—

Value

—

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Other

Date

Mar 2

39,552

Price

$15.91

Value

$629K

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Other

Date

Mar 2

40,302

Price

$15.91

Value

$641K

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Other

Date

Mar 2

79,104

Price

$15.91

Value

$1.26M ⚡

View Form 4 on SEC.gov

DIMITRIEF ALEXANDER

SVP, General Counsel and Sec.

Option

Date

Mar 2

16,816

Price

—

Value

—

View Form 4 on SEC.gov

DIMITRIEF ALEXANDER

SVP, General Counsel and Sec.

Other

Date

Mar 2

23,619

Price

$15.91

Value

$376K

View Form 4 on SEC.gov

Lyons Jonathan M.

Sr. Vice President, CFO

Award

Date

Mar 2

59,355

Price

—

Value

—

View Form 4 on SEC.gov

Lyons Jonathan M.

Sr. Vice President, CFO

Option

Date

Mar 2

17,937

Price

—

Value

—

View Form 4 on SEC.gov

Lyons Jonathan M.

Sr. Vice President, CFO

Other

Date

Mar 2

23,988

Price

$15.91

Value

$382K

View Form 4 on SEC.gov

Lyons Jonathan M.

Sr. Vice President, CFO

Other

Date

Mar 2

8,240

Price

$15.91

Value

$131K

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Award

Date

Mar 2

45,223

Price

—

Value

—

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Option

Date

Mar 2

14,573

Price

—

Value

—

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Other

Date

Mar 2

4,495

Price

$15.91

Value

$72K

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Other

Date

Mar 2

17,497

Price

$15.91

Value

$278K

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Sale

Date

Dec 8

394,861

Price

$16.45

Value

$6.50M ⚡

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Sale

Date

Dec 8

39,243

Price

$16.45

Value

$646K

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Sale

Date

Aug 22

126,611

Price

$16.38

Value

$2.07M ⚡

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Award

Date

Mar 3

298,953

Price

—

Value

—

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Other

Date

Mar 2

31,872

Price

$12.47

Value

$397K

View Form 4 on SEC.gov

Petras Michael B. Jr.

Chairman & CEO · Director

Other

Date

Mar 2

40,987

Price

$12.47

Value

$511K

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Award

Date

Mar 3

48,579

Price

—

Value

—

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Other

Date

Mar 2

4,198

Price

$12.47

Value

$52K

View Form 4 on SEC.gov

Rutz Michael P

President of Sterigenics

Other

Date

Mar 2

5,399

Price

$12.47

Value

$67K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About SHC insider trading

SHC insider trades

Sotera Health Company (SHC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Petras Michael B. Jr. (Chairman & CEO · Director), Rutz Michael P (President of Sterigenics), Lyons Jonathan M. (Sr. Vice President, CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. SHC insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Sotera Health Company's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

SHC insider trading · 5 questions

The insiders of Sotera Health Company (SHC) include executives and directors such as Petras Michael B. Jr. (Chairman & CEO · Director), Rutz Michael P (President of Sterigenics), Lyons Jonathan M. (Sr. Vice President, CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

SHC board member insider tradingwho are SHC insidersSHC insider rosterSotera Health Company executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026